Serological response to trivalent inactive influenza vaccine in HIV-infected children with different immunologic status

Vaccine

Volumn 29, Issue 16, 2011, Pages 3055-3060

  Kosalaraksa, Pope ^a   Srirompotong, Ussanee ^a   Newman, Robert W ^b   Lumbiganon, Pagakrong ^a   Wood, John M ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Children; HIV; Influenza vaccine; Serological response

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROCONVERSION; SEROLOGY; VACCINATION;

ADOLESCENT; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE TOLERANCE; IMMUNIZATION SCHEDULE; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; RNA, VIRAL; THAILAND; VACCINES, INACTIVATED;

EID: 79953202831     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.091     Document Type: Article

References (40)

1. Heikkinen T., Silvennoinen H., Peltola V., Ziegler T., Vainionpaa R., Vuorinen T., et al. Burden of influenza in children in the community. J Infect Dis 2004, 190(8):1369-1373.
2. Monto A.S., Sullivan K.M. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 1993, 110(1):145-160.
3. Neuzil K.M., Zhu Y., Griffin M.R., Edwards K.M., Thompson J.M., Tollefson S.J., et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 2002, 185(2):147-152.
4. Corbeel L. Should healthy children be vaccinated against influenza? Comments about this query. Eur J Pediatr 2007, 166(6):629-631.
5. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009, 58(RR-8):1-52.
6. Fuller J.D., Craven D.E., Steger K.A., Cox N., Heeren T.C., Chernoff D. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis 1999, 28(3):541-547.
7. Gunthard H.F., Wong J.K., Spina C.A., Ignacio C., Kwok S., Christopherson C., et al. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. J Infect Dis 2000, 181(2):522-531.
8. Lyall E.G., Charlett A., Watkins P., Zambon M. Response to influenza virus vaccination in vertical HIV infection. Arch Dis Child 1997, 76(3):215-218.
9. Malaspina A., Moir S., Orsega S.M., Vasquez J., Miller N.J., Donoghue E.T., et al. cell responses to influenza vaccination in HIV-infected individuals. J Infect Dis 2005, 191(9):1442-1450.
10. Diagnostic procedures for viral, rickettsial and chlamydial infections. 1979, Washington DC. 5th ed. E.H. Lenette, N.J. Schmidt (Eds.).
11. CPMP. Note for guidance on harmonisation of requirements for influenza vaccines. CPMP/BWP/214/96. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdf; 1997 [accessed 12.03.1997].
12. Stanley S.K., Ostrowski M.A., Justement J.S., Gantt K., Hedayati S., Mannix M., et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996, 334(19):1222-1230.
13. Tasker S.A., O'Brien W.A., Treanor J.J., Weiss P.J., Olson P.E., Kaplan A.H., et al. Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial. Vaccine 1998, 16(9-10):1039-1042.
14. Hughes M.D., Johnson V.A., Hirsch M.S., Bremer J.W., Elbeik T., Erice A., et al. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Ann Intern Med 1997, 126(12):929-938.
15. Raboud J.M., Montaner J.S., Conway B., Haley L., Sherlock C., O'Shaughnessy M.V., et al. Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection. J Infect Dis 1996, 174(1):191-194.
16. Chadwick E.G., Chang G., Decker M.D., Yogev R., Dimichele D., Edwards K.M. Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1994, 13(3):206-211.
17. Montoya C.J., Toro M.F., Aguirre C., Bustamante A., Hernandez M., Arango L.P., et al. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy. Mem Inst Oswaldo Cruz 2007, 102(4):501-508.
18. Cagigi A., Nilsson A., Pensieroso S., Chiodi F. Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy. Lancet Infect Dis 2010, 10:499-503.
19. Valdez H. Immune restoration after treatment of HIV-1 infection with highly active antiretroviral therapy (HAART). AIDS Rev 2002, 4(3):157-164.
20. Englund J.A., Walter E.B., Gbadebo A., Monto A.S., Zhu Y., Neuzil K.M. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Pediatrics 2006, 118(3):e579-e585.
21. Levin M.J., Song L.Y., Fenton T., Nachman S., Patterson J., Walker R., et al. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Vaccine 2008, 26(33):4210-4217.
22. Tanzi E., Esposito S., Bojanin J., Amendola A., Trabattoni D., Pariani E., et al. Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy. J Med Virol 2006, 78(4):440-445.
23. Vigano A., Zuccotti G.V., Pacei M., Erba P., Castelletti E., Giacomet V., et al. Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy. J Acquir Immune Defic Syndr 2008, 48(3):289-296.
24. Kendal A.P., Cate T.R. Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/222/79. J Clin Microbiol 1983, 18(4):930-934.
25. Monto A.S., Maassab H.F. Ether treatment of type B influenza virus antigen for the hemagglutination inhibition test. J Clin Microbiol 1981, 13(1):54-57.
26. Frank A.L., Taber L.H., Glezen W.P., Geyer E.A., McIlwain S., Paredes A. Influenza B virus infections in the community and the family. The epidemics of 1976-1977 and 1979-1980 in Houston, Texas. Am J Epidemiol 1983, 118(3):313-325.
27. Harmon M.W., Rota P.A., Walls H.H., Kendal A.P. Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J Clin Microbiol 1988, 26(2):333-337.
28. Bekker V., Scherpbier H., Pajkrt D., Jurriaans S., Zaaijer H., Kuijpers T.W. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Pediatrics 2006, 118(2):e315-e322.
29. Chehimi J., Campbell D.E., Azzoni L., Bacheller D., Papasavvas E., Jerandi G., et al. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J Immunol 2002, 168(9):4796-4801.
30. Correa R., Harari A., Vallelian F., Resino S., Munoz-Fernandez M.A., Pantaleo G. Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure. AIDS 2007, 21(1):23-30.
31. Kroon F.P., van Dissel J.T., de Jong J.C., Zwinderman K., van Furth R. Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. Vaccine 2000, 18(26):3040-3049.
32. Miotti P.G., Nelson K.E., Dallabetta G.A., Farzadegan H., Margolick J., Clements M.L. The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA 1989, 262(6):779-783.
33. Resino S., Correa R., Bellon J.M., Sanchez-Ramon S., Munoz-Fernandez M.A. Characterizing immune reconstitution after long-term highly active antiretroviral therapy in pediatric AIDS. AIDS Res Hum Retroviruses 2002, 18(18):1395-1406.
34. Resino S., Galan I., Bellon J.M., Navarro M.L., Leon J.A., Munoz-Fernandez M.A. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children. J Clin Immunol 2003, 23(4):279-289.
35. Vrisekoop N., van Gent R., de Boer A.B., Otto S.A., Borleffs J.C., Steingrover R., et al. Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging. J Immunol 2008, 181(2):1573-1581.
36. Glesby M.J., Hoover D.R., Farzadegan H., Margolick J.B., Saah A.J. The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study. J Infect Dis 1996, 174(6):1332-1336.
37. Ramilo O., Hicks P.J., Borvak J., Gross L.M., Zhong D., Squires J.E., et al. T cell activation and human immunodeficiency virus replication after influenza immunization of infected children. Pediatr Infect Dis J 1996, 15(3):197-203.
38. Fowke K.R., D'Amico R., Chernoff D.N., Pottage J.C., Benson C.A., Sha B.E., et al. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients. AIDS 1997, 11(8):1013-1021.
39. Keller M., Deveikis A., Cutillar-Garcia M., Gagajena A., Elkins K., Plaeger S., et al. Pneumococcal and influenza immunization and human immunodeficiency virus load in children. Pediatr Infect Dis J 2000, 19(7):613-618.
40. Yerly S., Wunderli W., Wyler C.A., Kaiser L., Hirschel B., Suter S., et al. Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load. AIDS 1994, 8(10):1503-1504.